Drugs / TAK-783
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00760968 | Aug 2007 → Feb 2009 | rheumatoid arthritis | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-783 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00760968 ↗ |
| Route | Oral | “TAK-783 100 mg, tablets, orally, once daily” NCT00760968 ↗ |